Veterans

Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026

SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...

HeyDonto AI Technology Closes $20 Million SEED Round at $200 Million Valuation to Scale Conduit – The Dental Interoperability Exchange

Funding will accelerate the deployment of the first standards-based interoperability platform connecting dental systems to the rest of healthcare, backed...

WEED Inc (OTCQB:BUDZ) Looks to Advance a High-Value AI Data Center Opportunity for The Four Winds of Lake Erie, LLC. On Our Prime Lake Erie Waterfront Property

Is Washington Bypassing Marijuana FDA’s Botanical Drug Pathway? Medicare’s $500 CBD Pilot Sparking Regulatory Firestorm

"As CMS Prepares to Launch the First Federal Cannabinoid Reimbursement Program, Industry Leaders Warn of a Dangerous Shift Toward "Access...

error: Content is protected !!